日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Achieving health equity in immune disease: leveraging big data and artificial intelligence in an evolving health system landscape

在免疫疾病领域实现健康公平：在不断变化的医疗体系中利用大数据和人工智能

期刊:Frontiers in Big Data
影响因子:2.3
doi:10.3389/fdata.2025.1621526
Kachnowski, Stan; Khan, Asif H; Floquet, Shadé; Whitlock, Kendal K; Wisnivesky, Juan Pablo; Neill, Daniel B; Dankwa-Mullan, Irene; Ortega, Gezzer; Daoud, Moataz; Zaheer, Raza; Hightower, Maia; Rowe, Paul
免疫/内分泌
发表日期：2025
文献求助 收藏

PARP-1 Inhibition Increases Oxidative Stress in Ets-1-Expressing MDA-MB-231 Breast Cancer Cells

PARP-1抑制会增加表达Ets-1的MDA-MB-231乳腺癌细胞的氧化应激

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70119
Hervieu, Magalie; Legrand, Arnaud J; Floquet, Emilie; Idziorek, Thierry; Spriet, Corentin; Monté, Didier; Villeret, Vincent; Aumercier, Marc; Choul-Li, Souhaila
肿瘤
肿瘤免疫
氧化应激
乳腺癌
PARP
细胞生物学
毒理研究
发表日期：2025
文献求助 收藏

Climaterna: A decade of daily data on births, deaths, pollution and climate variables for all municipalities in Brazil

Climaterna：巴西所有城市十年来的每日出生、死亡、污染和气候变量数据

期刊:Data in Brief
影响因子:1.4
doi:10.1016/j.dib.2025.111920
Torezzan, Cristiano; Soares, Camila Ferreira; de França, Breno Bernard Nicolau; Coltri, Priscila Pereira; de Lima, Everton Emanuel Campos; Xavier, Alexandre Cândido; Nichi, Jaqueline; Charles, Charles M'poca; Gallardo-Alvarado, Negli René; Floquet, Sergio; Motta, Gabriel Moreira; de Andrade, Matheus Alves; Risso, Mateus Samuel; Pereira, Malcolm Dos Reis Alves; Torres, Guilherme Almussa Leite; Hyslop, Kevin; Silva, Dimitri de Oliveira; Awe, Oluwafunmilola Deborah; Arantes, Caio Simplicio; Andrade Júnior, Valter Lacerda de; Pacagnella, Rodolfo de Carvalho
发表日期：2025
文献求助 收藏

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group

贝伐珠单抗、奥拉帕尼和度伐利尤单抗治疗复发性卵巢癌患者：GINECO 研究组的一项 II 期临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-45974-w
Freyer, Gilles; Floquet, Anne; Tredan, Olivier; Carrot, Aurore; Langlois-Jacques, Carole; Lopez, Jonathan; Selle, Frédéric; Abdeddaim, Cyril; Leary, Alexandra; Dubot-Poitelon, Coraline; Fabbro, Michel; Gladieff, Laurence; Lamuraglia, Michele
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group

作者更正：贝伐珠单抗、奥拉帕尼和度伐利尤单抗治疗复发性卵巢癌患者：GINECO 研究组的 II 期临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-48915-9
Freyer, Gilles; Floquet, Anne; Tredan, Olivier; Carrot, Aurore; Langlois-Jacques, Carole; Lopez, Jonathan; Selle, Frédéric; Abdeddaim, Cyril; Leary, Alexandra; Dubot-Poitelon, Coraline; Fabbro, Michel; Gladieff, Laurence; Lamuraglia, Michele
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Potentiating Activity of GmhA Inhibitors on Gram-Negative Bacteria

GmhA 抑制剂对革兰氏阴性细菌的增强活性

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.4c00037
François Moreau, Dmytro Atamanyuk, Markus Blaukopf, Marek Barath, Mihály Herczeg, Nuno M Xavier, Jérôme Monbrun, Etienne Airiau, Vivien Henryon, Frédéric Leroy, Stéphanie Floquet, Damien Bonnard, Robert Szabla, Chris Brown, Murray S Junop, Paul Kosma, Vincent Gerusz
微生物学
发表日期：2024
文献求助 收藏

Extended Sampling of Macromolecular Conformations from Uniformly Distributed Points on Multidimensional Normal Mode Hyperspheres

基于多维正态模式超球面上均匀分布点的宏观分子构象扩展采样

期刊:Journal of Chemical Theory and Computation
影响因子:5.5
doi:10.1021/acs.jctc.4c01054
S Gomes, Antoniel A; Costa, Mauricio G S; Louet, Maxime; Floquet, Nicolas; Bisch, Paulo M; Perahia, David
发表日期：2024
文献求助 收藏

Bee Together: Joining Bee Audio Datasets for Hive Extrapolation in AI-Based Monitoring

Bee Together：整合蜜蜂音频数据集，用于基于人工智能的蜂群推断监测

期刊:Sensors
影响因子:3.5
doi:10.3390/s24186067
Bricout, Augustin; Leleux, Philippe; Acco, Pascal; Escriba, Christophe; Fourniols, Jean-Yves; Soto-Romero, Georges; Floquet, Rémi
发表日期：2024
文献求助 收藏

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

在接受奥拉帕尼维持治疗的新诊断晚期卵巢癌且携带 BRCA 突变的患者中，7 年随访的总生存期：SOLO1/GOG 3004 试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.01549
DiSilvestro, Paul; Banerjee, Susana; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S; Gourley, Charlie; Oza, Amit; González-Martín, Antonio; Aghajanian, Carol; Bradley, William; Mathews, Cara; Liu, Joyce; McNamara, John; Lowe, Elizabeth S; Ah-See, Mei-Lin; Moore, Kathleen N
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial

HE4 和 CA-125 动力学预测复发性上皮性卵巢癌患者预后：META4 临床试验

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1308630
Fabbro, Michel; Lamy, Pierre-Jean; Touraine, Célia; Floquet, Anne; Ray-Coquard, Isabelle; Mollevi, Caroline
肿瘤
MET
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏